Catch-up hepatitisA vaccination not cost effective in USNo Abstract available for this article.doi:10.1007/s40274-016-3196-9NoneSpringer International PublishingPharmacoeconomics & Outcomes News
catch-up vaccination; hepatitis B; primary care ABSTRACT Background Hepatitis B vaccine was introduced into the regular immunization schedule in Israel in 1992. At the time, a need for a catch-up vaccination for those aged 4–18 years, became apparent. Study objective To evaluate the vaccination...
Hepatitis B vaccinewas incorporated into the recommended childhood immunization schedule in 1990. Adults born before 1990 may require the full three-dose hepatitis B vaccine primary series as a catch-up vaccine for protection against inadvertent exposures associated with travel. ...
Hepatitis A is a viral infection that affects your liver. The effects usually aren't as long-lasting or serious as other types of hepatitis. You pick up the virus either by contact with someone who has it or by eating or drinking something contaminated by the virus. There's no specific t...
Hutton DW, So SK, Brandeau ML: Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology 2010,... DW Hutton,SK So,ML Brandeau - 《Hepatology》 被引量: 99发表: 2010年 Cost-effective analysis of hepatitis a prevention in Ireland OBJE...
The children typically show up at hospitals scattered across the country, one or two at a time, with symptoms like unexplained vomiting, diarrhea and jaundice. These are the classic signs of hepatitis—inflammation of the liver—yet in many cases, no cau
You can prevent infection with a vaccine. The CDC recommends that babies get their first dose shortly after they're born. They'll need follow-up shots when they're between 6 and 18 months old. Kids under age 19 who missed any shots in the series should get catch-up doses. ...
The hepatitis B vaccine has been linked to neurological disorders, multiple sclerosis, and death. In spite of medical denials, research indicates a likely connection.
However, up to 15–32% of treated patients may become HBsAg-negative. Patients with advanced cirrhosis Patients with cirrhosis and ascites, encephalopathy or persistent jaundice from chronic hepatitis B have a dire prognosis without treatment, but are prone to developing multiple, serious side-effects...
Hepatitis B virus(HBV) is a double-stranded DNA virus that is a member of theHepadnaviridaefamily. The worldwide burden ofHBVinfection is estimated to involve up to 400 million people with the majority of affected patients found in the developing world, particularly Africa and Asia. HBV can ...